Indaptus Therapeutics
INDP
6 hedge funds and large institutions have $13.4M invested in Indaptus Therapeutics in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
7% less capital invested
Capital invested by funds: $14.4M → $13.4M (-$1.02M)
25% less funds holding
Funds holding: 8 → 6 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$321K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$12.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$424K |
| 2 |
Jane Street
New York
|
-$194K |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$89.9K |
| 4 |
IAM
Ion Asset Management
Herzliya,
Israel
|
-$56K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CAM
1
Cormorant Asset Management
Boston,
Massachusetts
| $4.29M | – | – | – |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $3.59M | +$321K | +25 | +9% |
|
|
OM
3
Opaleye Management
Boston,
Massachusetts
| $3.38M | – | – | – |
|
|
PA
4
Perceptive Advisors
New York
| $1.47M | -$424K | -33 | -21% |
|
|
DCM
5
DAFNA Capital Management
Los Angeles,
California
| $639K | -$89.9K | -7 | -12% |
|
|
6
UBS Group
Zurich,
Switzerland
| $22K | +$12.8K | +1 | +100% |
|
|
7
Jane Street
New York
| – | -$194K | -15 | Closed |
|
|
IAM
8
Ion Asset Management
Herzliya,
Israel
| – | -$56K | -4 | Closed |
|
INDP Hedge Fund Activity: Q4 2015 in Review
6 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Indaptus Therapeutics (INDP) for Q4 2015, worth a combined $13.4M — down 7.1% from $14.4M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of INDP and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Sabby Management, adding an estimated $321K. The largest seller was Perceptive Advisors, cutting an estimated $424K.
- 6 institutional investors held Indaptus Therapeutics (INDP) as of Q4 2015, down from 8 in Q3 2015.
- Funds reported $13.4M of Indaptus Therapeutics stock for Q4 2015, down 7.1% quarter-over-quarter.
- 0 funds opened new Indaptus Therapeutics positions in Q4 2015 and 2 closed out, a net change of -2 holders.
- The largest Indaptus Therapeutics buyer in Q4 2015 was Sabby Management, an estimated $321K added.
- The largest Indaptus Therapeutics seller in Q4 2015 was Perceptive Advisors, an estimated $424K sold.
Based on aggregated 13F filings for Q4 2015.